Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05920616 · ClinicalTrials.gov registry record · NA
Comprehensive Imaging Exam of Convalesced COVID-19 Patients
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 206
- Enrollment target
NCT05920616: Completed NA study, sponsored by Johns Hopkins University.
NCT05920616 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 206 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05920616, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
Study Summary
COVID-19 is a systemic inflammatory disease involving many organs including the lungs, vascular system liver and myocardium that lead to severe pathologies. Patients with severe cardiopulmonary symptoms usually require weeks to months to fully recover. Studies of clinical and subclinical impairments of COVID-19 patients are important for medical practice and public health as well as providing pathogenic insight to the viral infection and secondary immune response. Chronic damage of vital organs and systems, and the potential long-term effects is of serious concern. In this study the investigators plan to quantify and characterize chronic consequences of COVID-19 in individuals who receive similar medical care related to disease severity and duration in a single health care system. Using state-of-the-art Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) technology, we will study the pathology in major organ systems in comparison to matched controls. The results of this study may facilitate measures to prevent, detect, and manage complications from COVID-19 infections.
Interventions
- OTHER Magnetic Resonance Imaging
- OTHER Ultra-High Resolution Computed Tomography (CT) Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2020-10-14 |
| Est. Completion | 2026-05-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05920616
The ClinicalTrials.gov registry entry for NCT05920616 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT05920616 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05920616 about?
NCT05920616 is a clinical study titled "Comprehensive Imaging Exam of Convalesced COVID-19 Patients". COVID-19 is a systemic inflammatory disease involving many organs including the lungs, vascular system liver and myocardium that lead to severe pathologies. Patients with severe cardiopulmonary symptoms usually require weeks to months to fully recover. Studies of clinical and subclinical impairments...
What is the current status of trial NCT05920616?
This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2020-10-14. Estimated completion is 2026-05-15.
What interventions are being tested in trial NCT05920616?
The interventions under investigation include: Magnetic Resonance Imaging (OTHER), Ultra-High Resolution Computed Tomography (CT) Scan (OTHER).
Who is sponsoring clinical trial NCT05920616?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.